Because of its tissue apposition capabilities and easy en face application, OTSC is used as
In 7/10 patients with enterocutaneous fistula, OTSC application resulted in complete fistula closure. While NSQIP
Conference Report of the American College of Gastroenterology (ACG) 2019: OTSC®: Besides a RCT showing
In 851 patients from 21 studies, definitive hemostasis was reached in 87.8 %, technical success
Ovesco Messestand
Conference Report of the United European Gastroenterology Week (UEGW) 2019: OTSC® shows superiority over conventional
A randomized controlled trial presented at the American College of Gastroenterology (ACG) meeting shows the
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section
Ovesco Endoscopy is pleased to announce that the stentfix OTSC® System Set has received market
93 % primary hemostasis was achieved with primary OTSC therapy (288 patients), 91 % with
Pooled durable clinical success proportions of OTSC use were 87.5 % in hemorrhage, 81.4 %